Inhibition of levodopa metabolism to dopamine by honokiol short-chain fatty acid derivatives may enhance therapeutic efficacy in Parkinson’s disease is a research paper published in Scientific Reports (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centre National de la Recherche Scientifique
Grant: International Research Project SuperO2
National Institute of Neurological Disorders and Stroke
Grant: R21NS137244
National Cancer Institute
Grant: R01CA208648
National Institutes of Health
Grant: 5R21NS137244-02
Modifying the microbiome to enhance L-dopa therapy in Parkinson’s disease
National Institutes of Health
Grant: 5R01CA208648-03
Chemoprevention of lung cancer with mitochondria-targeted honokiol
Harry R. and Angeline E. Quadracci Professor in Parkinson’s Research Endowment
Advancing a Healthier Wisconsin Endowment
MeSH Terms
Keywords